Transcatheter closure of secundum atrial septal defect

被引:15
作者
Shimpo H. [1 ]
Hojo R. [1 ]
Ryo M. [1 ]
Konuma T. [1 ]
Tempaku H. [1 ]
机构
[1] Department of Thoracic and Cardiovascular Surgery, Mie University School of Medicine, Tsu Mie 514-8507
关键词
Amplatzer septal occluder; Atrial septal defect; Transcatheter closure;
D O I
10.1007/s11748-013-0268-7
中图分类号
学科分类号
摘要
Since the introduction of transcatheter closure of atrial septal defect, device closure has become the alternative treatment of selected atrial defects. Although excellent results have been reported for transcatheter closure, concerns have arisen regarding complications, including residual shunt, systemic or pulmonary embolization of the device, and erosion and perforation of the cardiac chamber. Those complications are rare but potentially serious adverse events that may require immediate surgical intervention. This review summarizes the current trends in patient selection, result of device closure and typical complications. Comparison between transcatheter device closure and surgical closure is also made. © 2013 The Japanese Association for Thoracic Surgery.
引用
收藏
页码:614 / 618
页数:4
相关论文
共 49 条
  • [1] Sakata R., Fuji Y., Kuwano H., Thoracic and cardiovascular surgery in Japan during 2009, Gen Thorac Cardiovasc Surg, 59, pp. 636-667, (2011)
  • [2] King T.D., Mills N.L., Nonoperative closure of atrial septal defects, Surgery, 75, pp. 383-388, (1974)
  • [3] Hijazi Z.M., Cao Q., Patel H.T., Rhodes J., Hanlon K.M., Transesophageal echocardiographic results of catheter closure of atrial septal defect in children and adults using the Amplatzer device, Am J Cardiol, 85, pp. 1387-1390, (2000)
  • [4] Majunke N., Sievert H., ASD/PFO devices: What is in the pipeline?, J Interv Cardiol, 20, pp. 517-523, (2007)
  • [5] Kim M.S., Klein A.J., Carroll J.D., Transcatheter closure of intracardiac defects in adults, J Interv Cardiol, 20, pp. 524-545, (2007)
  • [6] Masura J., Gavora P., Formanek A., Hijazi Z.M., Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: Initial human experience, Cathet Carduivasc Dian, 42, pp. 388-393, (1997)
  • [7] Latson L.A., Per-catheter ASD closure, Pediatr Cardiol, 19, pp. 86-93, (1998)
  • [8] Everett A.D., Jennings J., Sibinga E., Owada C., Lim D.S., Cheatham J., Et al., Community use of the amplatzer atrial septal defect occlude: Results of the multicenter MAGIC atrial septal defect study, Pediatr Cardiol, 30, pp. 240-247, (2009)
  • [9] Slavin L., Tobis J.M., Rangarajan K., Dao C., Krivokapich J., Liebeskind D.S., Five-year experience with percutaneous closure of patent foramen ovale, Am J Cardiol, 99, pp. 1316-1320, (2007)
  • [10] Hein R., Buscheck F., Fischer E., Leetz M., Bayard M.T.Y., Ostermayer S., Et al., Atrial and ventricular septal defects can safely be closed by percutaneous intervention, J Interv Cardiol, 18, pp. 515-522, (2005)